Oriol Arpí
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 16
- Lung Cancer Research Studies 7
- Peptidase Inhibition and Analysis 5
- HER2/EGFR in Cancer Research 4
-
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Ana Rovira (21 shared papers)Joan Albanell (19 shared papers)Federico Rojo (14 shared papers)Sílvia Menéndez (12 shared papers)Sandra Zazo (8 shared papers)Edurne Arriola (7 shared papers)Álvaro Taus (6 shared papers)Aňa Lluch (6 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Oncotarget (3 papers)Molecular Cancer Therapeutics (2 papers)European Journal of Cancer (2 papers)OncoImmunology (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Oriol Arpí
24 papers receiving 700 citations
Peers
Comparison fields: 5 of 77
- Oncology 376
- Cancer Research 149
- Hepatology 64
- Molecular Biology 359
- Immunology 86
Countries citing papers authored by Oriol Arpí
This map shows the geographic impact of Oriol Arpí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol Arpí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol Arpí more than expected).
Fields of papers citing papers by Oriol Arpí
This network shows the impact of papers produced by Oriol Arpí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol Arpí. The network helps show where Oriol Arpí may publish in the future.
Co-authors
The 25 scholars most cited alongside Oriol Arpí, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 107 | |
| 2 | 2017 | 92 | |
| 3 | 2015 | 82 | |
| 4 | 2019 | 66 | |
| 5 | 2011 | 47 | |
| 6 | 2019 | 42 | |
| 7 | Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines. | 2016 | 37 |
| 8 | 2013 | 37 | |
| 9 | 2014 | 34 | |
| 10 | 2019 | 27 | |
| 11 | 2017 | 27 | |
| 12 | 2020 | 24 | |
| 13 | 2014 | 22 | |
| 14 | 2020 | 21 | |
| 15 | 2015 | 18 | |
| 16 | 2013 | 10 | |
| 17 | 2023 | 6 | |
| 18 | 2019 | 4 | |
| 19 | 2022 | 2 | |
| 20 | 2017 | 1 |
About Oriol Arpí
Oriol Arpí is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 24 papers that have together received 710 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Peptidase Inhibition and Analysis (5 papers), HER2/EGFR in Cancer Research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Glioma Diagnosis and Treatment (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (376 citations), Cancer Research (149 citations), Hepatology (64 citations), Molecular Biology (359 citations) and Immunology (86 citations). Oriol Arpí has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Ana Rovira, Joan Albanell, Federico Rojo, Sílvia Menéndez, Sandra Zazo, Edurne Arriola, Álvaro Taus, Aňa Lluch, Pîlar Eroles and Israel Cañadas. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Molecular Cancer Therapeutics, European Journal of Cancer and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.